AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2020
Sep 18, 2020
32777_dirs_2020-09-18_8f41810a-1820-4b95-a388-62ee62e48c32.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2020-07-14
Reporting Person: GLAXOSMITHKLINE PLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-14 | Common Stock | S | 1597 | $19.2740 | Disposed | 1913678 | Indirect |
| 2020-07-15 | Common Stock | S | 3069 | $19.4016 | Disposed | 1910609 | Indirect |
| 2020-07-15 | Common Stock | S | 78 | $19.25 | Disposed | 1910531 | Indirect |
Footnotes
F1: The shares reported herein are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (the "Reporting Person").
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Regulatory Filings
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Feb 3